Follow-up research validating cNST-immunity findings published by end of 2026? | Binary | | | 8 months ago | |
First Targeted Inflammatory Disease for cNST-Based Treatments by 2025 | Categorical | | | 8 months ago | |
Pharma partnerships for cNST-based treatments formed by mid-2025? | Binary | | | 8 months ago | |
First application focus of cNST findings by end of 2025 | Categorical | | | 8 months ago | |
Type of therapy first utilized from cNST findings by end of 2026 | Categorical | | | 8 months ago | |
Clinical trials based on cNST findings initiated by end of 2025? | Binary | | | 8 months ago | |
First Treatment Method from cNST Study to Enter Phase I Trials by 2026 | Categorical | | | 8 months ago | |
Clinical Trial Announcement based on cNST Study by 2024? | Binary | | | 8 months ago | |
Pharma Partnerships Initiated for cNST Research by Mid-2025? | Binary | | | 8 months ago | |
New Patent Filings for cNST-Related Techniques by 2024? | Binary | | | 8 months ago | |
Funding level for cNST research over the next 3 years | Categorical | | | 8 months ago | |
Next Academic Collaborator with ColumbiaMed on cNST Research by 2024 | Categorical | | | 8 months ago | |
